Genoscience Pharma
Phase 1We are conceptualizing and developing disruptive and innovative science from bench to bedside for improving the conditions of patients in serious unmet medical needs.
Founded
2008
Focus
Small Molecules
About
We are conceptualizing and developing disruptive and innovative science from bench to bedside for improving the conditions of patients in serious unmet medical needs.
Funding History
2Total raised: $35M
Series B$25MBpifranceOct 15, 2020
Series A$10MBpifranceApr 15, 2018
Company Info
TypePrivate
Founded2008
LocationMarseille, France
StagePhase 1
Contact
Sectors
SIMILAR COMPANIES
4P-Pharma
Phase 2 · Lille
Patheon
Pre-clinical · Lyon
ABL Diagnostics
Pre-clinical · Strasbourg
Acticor Biotech
Pre-clinical · Paris
Adjuvatis
Pre-clinical · Lyon
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile